Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,357,666
+$2,090,865 QoQ
Shares Held
9,034
+84.2% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#133
of 419 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. KRYS ranks #41 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in KRYS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,357,666 | 9,034 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,266,801 | 4,904 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,109,676 | 4,501 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,936,040 | 39,291 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,243,549 | 38,146 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,485,695 | 41,518 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,341,205 | 27,711 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $945,463 | 5,194 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $910,303 | 4,957 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $516,174 | 2,901 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,681,232 | 29,673 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $2,066,108 | 25,807 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,045,460 | 25,820 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,901,764 | 27,285 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||